Raloxifene | No treatment | P value | ||
---|---|---|---|---|
Age (years) | 74.24 ± 7.62 | 72.52 ± 9.70 | 0.238 | |
Body mass index (kg/m2) | 22.80 ± 4.82 | 24.12 ± 4.85 | 0.116 | |
Survival years | 8.06 ± 2.63 | 6.11 ± 4.33 | 0.004 | |
Fracture no (spine) | 1.83 ± 1.07 | 1.48 ± 1.48 | 0.158 | |
Previous hip fracture | No | 46(90.2 %) | 88(89.8 %) | 0.592 |
Yes | 5(9.8 %) | 10(10.2 %) | ||
Diabetes | No | 38(74.5 %) | 73(74.5 %) | 0.581 |
Yes | 13(25.5 %) | 25(25.5 %) | ||
Hypertension | No | 25(49.0 %) | 46(46.9 %) | 0.864 |
Yes | 26(51.0 %) | 52(53.1 %) | ||
Neurological disease | No | 50(98.0 %) | 97(99.0 %) | 1 |
Yes | 1(2.0 %) | 1(1.0 %) | ||
Pulmonary disease | No | 49(96.1 %) | 92(93.9 %) | 0.716 |
Yes | 2(3.9 %) | 6(6.1 %) | ||
Cardiovascular disease | No | 49(96.1 %) | 93(94.9 %) | 1 |
Yes | 2(3.9 %) | 5(5.1 %) | ||
Liver disease | No | 47(92.2 %) | 91(92.9 %) | 1 |
Yes | 4(7.8 %) | 7(7.1 %) |